A month after desi Ozempic’s debut, vitamin market expands 10%
MUMBAI: Just a month after the Ozempic-famed weight-loss and diabetes medicine semaglutide entered the market as a generic, there has been a sudden surge in the demand for nutraceuticals, like multivitamin supplements. As patients on GLP-1 receptor agonists, a new class of anti-obesity medicines, face the risk of micronutritional loss, these supplements are being prescribed…